bioRASI

Executive Summary

bioRASI is a privately held clinical research organization (CRO) based in Miami, Florida, founded in 2003. Operating at the intersection of clinical research and digital health, the company offers comprehensive clinical trial services with a focus on leveraging technology to accelerate drug development. With over two decades of experience, bioRASI has established itself as a niche player in the CRO space, particularly serving small to mid-size biotech and pharmaceutical clients. The company's integration of digital health tools into traditional clinical trial operations positions it well to capitalize on the growing trend toward decentralized and hybrid trials, which have gained momentum post-pandemic. While bioRASI remains private and has not disclosed funding or valuation, its longevity and adaptability suggest a stable business model with potential for growth as demand for efficient, tech-enabled CRO services increases.

Upcoming Catalysts (preview)

• Q3 2026Adoption of Decentralized Trial Technologies70% success
• Q4 2026Strategic Partnership with a Major Pharma40% success
• Q2 2027Expansion into Latin American Markets50% success